What is Alzheimer's disease?
Alzheimer’s disease is the most common cause of dementia, thought to account for over 50% of cases. Like most other types of dementia, Alzheimer’s disease is progressive, with symptoms worsening over time.
The brain changes typically found in Alzheimer's disease were first described by the German psychiatrist Alois Alzheimer in 1906.
Alzheimer’s disease used to be most frequently diagnosed when people already had dementia and were experiencing quite noticeable problems with memory loss, thinking ability and daily activities.
Nowadays, Alzheimer’s disease is considered a continuum ranging from a pre-clinical (at-risk for dementia) state, to a form of mild cognitive impairment with only minor problems with daily activities and on to mild, moderate and severe dementia with increasing loss of cognitive and everyday function.
The disease progression
Alzheimer’s disease begins many years before symptoms become apparent and develops gradually over time.
As people progress along the Alzheimer’s disease continuum, cognitive and functional impairments gradually become more severe, with an eventual loss of independence and hence, a need for support from other people. However, it is important to understand that progression along the Alzheimer’s disease continuum varies considerably from person to person and that each person’s experience of Alzheimer’s disease will be unique to them.
Moreover, in keeping with the United Nations Convention on the Rights of People with Disabilities, dementia is also considered a disability. Article 1 states:
"(p)ersons with disabilities include those who have long-term physical, mental, intellectual or sensory impairments which in interaction with various barriers may hinder their full and effective participation in society on an equal basis with others"
For this reason, it is important to consider the physiological/biomedical aspects of Alzheimer’s disease but also the interaction between people with cognitive impairment, other people, situations and societal structures as this, in addition, impacts on the wellbeing, opportunities and overall experience of having dementia.
Latest news

News
How can you influence dementia research?
Are you interested in brain health and want to influence dementia research? If yes, please join the Public Involvement Pool, created by Alzheimer Europe (PREDICTOM parnter).

News
Are you a general practitioner?
PREDICTOM is inviting general practitioners to take part in our survey. With the aim of identifying current clinical guidelines and practice for screening, identifying and diagnosing Alzheimer's Disease and early dementia, we want to hear your views.

News
Ensuring the success of PREDICTOM through effective partnership management
Robin Verjans, Program Manager at Lygature, highlights the importance of effective project management in PREDICTOM which supports the day-to-day work of each partner and ultimately ensures the achievement of PREDICTOM's objectives.